BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 6802539)

  • 1. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
    Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
    Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver autoreactivity in acute virus A, B and non-A, non-B hepatitis.
    Vento S; McFarlane BM; McSorley CG; Ranieri S; Giuliani-Piccari G; Dal Monte PR; Verucchi G; Williams R; Chiodo F; McFarlane IG
    J Clin Lab Immunol; 1988 Jan; 25(1):1-7. PubMed ID: 3133482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.
    Kakumu S; Arakawa Y; Goji H; Kashio T; Yata K
    Gastroenterology; 1979 Apr; 76(4):665-72. PubMed ID: 105959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species cross-reactivity of anti-LSP antibodies in acute viral hepatitis.
    Perperas A; McFarlane BM; McSorley CG; McFarlane IG; Williams R
    J Clin Lab Immunol; 1986 Jan; 19(1):25-30. PubMed ID: 2422379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunology of liver diseases].
    Meyer zum Büschenfelde KH
    Schweiz Med Wochenschr; 1987 Jul; 117(29):1065-75. PubMed ID: 3313682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?
    Meyer zum Büschenfelde KH; Manns M; Hütteroth TH; Hopf U; Arnold W
    Clin Exp Immunol; 1979 Aug; 37(2):205-12. PubMed ID: 498582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].
    Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G
    Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IgG antibody reactivity of sera from patients with active chronic hepatitis to a crude liver antigen and liver specific protein (LSP): analysis by ELISA and immunoblotting.
    Sundin U; Heigl Z; Sundqvist KG
    Clin Exp Immunol; 1988 Nov; 74(2):276-82. PubMed ID: 3265656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-HBc within the framework of hepatitis B virus infection: correlation to the form of inflammation and to the viral expression].
    Endo Y; Gudat F; Bianchi L; Mihatsch M; Gasser M; Stalder GA; Schmid M
    Schweiz Med Wochenschr; 1978 Mar; 108(10):363-73. PubMed ID: 625636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial observation of lymphocyte subpopulations and interleukin 2 production of T cells from patients with acute viral hepatitis and chronic active hepatitis.
    Onji M; Kondo H; Ohta Y
    Hepatogastroenterology; 1988 Feb; 35(1):10-3. PubMed ID: 3129350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to ribosomes in chronic active hepatitis.
    Gerber MA; Shapiro JM; Smith H; Lebwohl O; Schaffner F
    Gastroenterology; 1979 Jan; 76(1):139-43. PubMed ID: 758135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin.
    Brown C; Pedersen J; Underwood JR; Gust I; Toh BH
    J Clin Lab Immunol; 1986 Jan; 19(1):1-4. PubMed ID: 3084793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic active hepatitis and related disorders.
    Larcher V
    Clin Gastroenterol; 1986 Jan; 15(1):173-98. PubMed ID: 3082542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic hepatitis as sequela of acute viral hepatitis A and hepatitis non A - non B (author's transl)].
    Müller R; Willers H; Freise J; Höpken W
    Z Gastroenterol; 1978 Dec; 16(12):760-7. PubMed ID: 741846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease.
    Thestrup-Pedersen K; Ladefoged K; Andersen P
    Clin Exp Immunol; 1976 Apr; 24(1):1-8. PubMed ID: 949867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis.
    Kakumu S; Hara T; Gohji H; Sakamoto N
    Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral and autoimmune hepatitis. Morphologic and pathogenetic aspects of cell damage in hepatitis with potential chronicity.
    Dienes HP
    Veroff Pathol; 1989; 132():1-107. PubMed ID: 2524940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.
    Hopf U; Meyer zum Büschenfelde KH; Arnold W
    N Engl J Med; 1976 Mar; 294(11):578-82. PubMed ID: 1107836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum binding activity for polymerized human albumin due to antibodies detected by enzyme-linked immunosorbent assay in acute and chronic type B, A and NANB viral hepatitis.
    Baraldini M; Miglio F; Cursaro C; Stefanini GF; Micaletti E; Pontisso P; Alberti A; Gasbarrini G
    Ric Clin Lab; 1987; 17(2):131-42. PubMed ID: 3114866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral immunity in viral hepatitis.
    Lee WM
    Am J Clin Pathol; 1976 May; 65(5 Suppl):866-9. PubMed ID: 85410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.